0001181431-13-047080.txt : 20130830 0001181431-13-047080.hdr.sgml : 20130830 20130830162924 ACCESSION NUMBER: 0001181431-13-047080 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20130827 FILED AS OF DATE: 20130830 DATE AS OF CHANGE: 20130830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regado Biosciences Inc CENTRAL INDEX KEY: 0001311596 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030422069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 MOUNTAIN VIEW BOULEVARD CITY: BASKING RIDGE STATE: NJ ZIP: 00000 BUSINESS PHONE: 908.580.2111 MAIL ADDRESS: STREET 1: 120 MOUNTAIN VIEW BOULEVARD CITY: BASKING RIDGE STATE: NJ ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RusnanoMedInvest LLC CENTRAL INDEX KEY: 0001579466 STATE OF INCORPORATION: 1Z FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35953 FILM NUMBER: 131072765 BUSINESS ADDRESS: STREET 1: 1-ST BRESTSKAYA STR., 29/22 CITY: MOSCOW STATE: 1Z ZIP: 125047 BUSINESS PHONE: 074955453912 MAIL ADDRESS: STREET 1: 1-ST BRESTSKAYA STR., 29/22 CITY: MOSCOW STATE: 1Z ZIP: 125047 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RMI Investments S.a.r.l. CENTRAL INDEX KEY: 0001579787 STATE OF INCORPORATION: 1Z FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35953 FILM NUMBER: 131072766 BUSINESS ADDRESS: STREET 1: 17, RUE DES JARDINIERS CITY: LUXEMBOURG STATE: N4 ZIP: L-1835 BUSINESS PHONE: 79851530799 MAIL ADDRESS: STREET 1: BUSINESS-CENTER 29/22 STREET 2: CAPITAL TOWER 1-ST BRESTSKAYA STREET CITY: MOSCOW STATE: 1Z ZIP: 125047 4/A 1 rrd389456.xml FORM 4A X0306 4/A 2013-08-27 2013-08-29 0 0001311596 Regado Biosciences Inc RGDO 0001579787 RMI Investments S.a.r.l. BUSINESS-CENTER 29/22 CAPITAL TOWER 1-ST BRESTSKAYA STREET MOSCOW 1Z 125047 RUSSIAN FEDERATION 0 0 1 0 0001579466 RusnanoMedInvest LLC BUSINESS-CENTER 29/22 CAPITAL TOWER 1-ST BRESTSKAYA STREET MOSCOW 1Z 125047 RUSSIAN FEDERATION 0 0 1 0 Common Stock, par value $0.001 per share 2013-08-27 4 C 0 1369988 A 1369988 D Common Stock, par value $0.001 per share 2013-08-27 4 P 0 3866529 4.00 A 5236517 D Series E Preferred Stock 2013-08-27 4 C 0 22878805 0 D Common Stock, par value $0.001 per share 1369988 0 D The reportable securities are directly held by the Reporting Person. The Reporting Person is a wholly-owned subsidiary of RusnanoMedInvest LLC ("RMI LLC"). RMI LLC has voting and dispositive power over the shares held by the Reporting Person. The shares of Series E Preferred Stock had no expiration date and automatically converted upon the consummation of the initial public offering of Regado Biosciences, Inc. (the "Company") at a conversion ratio of 1 share of Series E Preferred Stock to 0.05988024 shares of common stock, for no additional consideration. This amendment is being filed solely to include as an exhibit the power of attorney granting authorization to the signatory to act on RMI LLC's behalf in connection with its Form 4 filings regarding its holdings in the Company. RMI Investments S.a.r.l. By: /s/ Christopher Courts, Attorney-in-Fact 2013-08-30 RusnanoMedInvest LLC By: /s/ Christopher Courts, Attorney-in-Fact 2013-08-30 EX-24.1 2 rrd350374_396701.htm POWER OF ATTORNEY rrd350374_396701.html


                                   POWER OF ATTORNEY

     Know all by these presents, that the undersigned on behalf of
RMI Investments S.a.r.l., a legal entity organized and existing under the laws of
Luxembourg, having its registered office at 17, rue des Jardiniers, L-1835 Luxembourg,
Grand Duchy of Luxembourg ("RMI"), hereby authorizes David  J. Mazzo, the President
and Chief Executive Officer of Regado Biosciences, Inc. (the "Company"), and
Christopher E. Courts, the Vice President, Finance of the Company, or either of
them signing singly, and with full power of substitution, the undersigned's true
 and lawful attorneys-in-fact to:

     (1) execute for and on behalf of the undersigned, in the undersigned's capacity
     as an officer and/or director of the Company, Forms 3, 4, and 5 in accordance
     with Section 16(a) of the Securities Exchange Act of 1934, as amended, and
     the rules thereunder;

     (2) do and perform any and all acts for and on behalf of the undersigned which
     may be necessary or desirable to complete and execute any such Form 3, 4,
     or 5, complete and execute any amendment or amendments thereto, and timely
     file such form with the United States Securities and Exchange Commission
     and any stock exchange or similar authority; and

     (3) take any other action of any type whatsoever in connection with the
     foregoing which, in the opinion of such attorneys-in-fact, may be of benefit
     to, in the best interest of, or legally required by, the undersigned, it
     being understood that the documents executed by such attorneys-in-fact on
     behalf of the undersigned pursuant to this Power of Attorney shall be in
     such form and shall contain such terms and conditions as such attorneys-in-fact
     may approve in such attorneys-in-fact's discretion.

     The undersigned on behalf of RMI hereby grants to the foregoing attorneys-in-fact
full power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorneys-in-fact, or such
attorneys-in-fact's designated substitute or substitutes, shall lawfully do or
cause to be done by virtue of this Power of Attorney and the rights and powers
herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact,
in serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules
thereunder.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 19th day of August, 2013.


                                              RMI Investments S.a.r.l.


                                              By:  /s/ Vladimir Gurdus
                                                 --------------------------
                                                 Name: Vladimir Gurdus
                                                 Title: Director Category A




EX-24.2 3 rrd350374_396704.htm POWER OF ATTORNEY rrd350374_396704.html
                               POWER OF ATTORNEY

       Know all by these presents, that the undersigned on behalf of
RusnanoMedInvest LLC hereby authorizes David  J. Mazzo, the President and Chief
Executive Officer of Regado Biosciences, Inc. (the "Company"), and Christopher
E. Courts, the Vice President, Finance of the Company, or either of them signing
singly, and with full power of substitution, the undersigned's true and lawful
attorneys-in-fact to:

       (1) execute for and on behalf of the undersigned, in the undersigned's
       capacity as an officer and/or director of the Company, Forms 3, 4, and 5
       in accordance with Section 16(a) of the Securities Exchange Act of 1934,
       as amended, and the rules thereunder;

       (2) do and perform any and all acts for and on behalf of the undersigned
       which may be necessary or desirable to complete and execute any such Form
       3, 4, or 5, complete and execute any amendment or amendments thereto, and
       timely file such form with the United States Securities and Exchange
       Commission and any stock exchange or similar authority; and

       (3) take any other action of any type whatsoever in connection with the
       foregoing which, in the opinion of such attorneys-in- fact, may be of
       benefit to, in the best interest of, or legally required by, the
       undersigned, it being understood that the documents executed by such
       attorneys-in-fact on behalf of the undersigned pursuant to this Power of
       Attorney shall be in such form and shall contain such terms and
       conditions as such attorneys-in-fact may approve in such attorneys-in-
       fact's discretion.

       The undersigned on behalf of RusnanoMedInvest LLC hereby grants to the
foregoing attorneys-in-fact full power and authority to do and perform any and
every act and thing whatsoever requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming all
that such attorneys-in-fact, or such attorneys-in-fact's designated substitute
or substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity at the request
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended, and the rules thereunder.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys -in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 30th day of August, 2013.

                             RusnanoMedInvest LLC


                             By:  /s/ Vladimir Gurdus
                                  ---------------------------------------
                                  Name: Vladimir Gurdus
                                  Title: Direct of D-Pharma, LLC, the management
                                         company of RusnanoMedInvest LLC